Lei Jiang
- Molecular Biology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Plant Science top 5%
- Oncology top 10%
- Topics
- MicroRNA in disease regulation (17 papers)RNA modifications and cancer (16 papers)Cancer-related molecular mechanisms research (15 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lei Jiang
129 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 2.0k
- Cancer Research 985
- Pulmonary and Respiratory Medicine 523
- Plant Science 523
- Oncology 429
Countries citing papers authored by Lei Jiang
This map shows the geographic impact of Lei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Jiang more than expected).
Fields of papers citing papers by Lei Jiang
This network shows the impact of papers produced by Lei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Jiang. The network helps show where Lei Jiang may publish in the future.
Co-authorship network of co-authors of Lei Jiang
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Jiang. A scholar is included among the top collaborators of Lei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Jiang. Lei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 5 | |
| 6 | 33 | |
| 7 | 67 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 65 | |
| 11 | 15 | |
| 12 | 52 | |
| 13 | 0 | |
| 14 | CSR1 suppresses tumor growth and metastasis of human hepatocellular carcinoma via inhibition of HPIP. | 5 |
| 15 | 2 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 25 | |
| 19 | 129 | |
| 20 | Survey of statin usage in 4429 diabetic patients with atherosclerostic cardiovascular disease in China | 2 |
About Lei Jiang
Lei Jiang is a scholar working on Cancer Research, Molecular Biology and Toxicology, having authored 141 papers that have together received 3.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), RNA modifications and cancer (16 papers) and Cancer-related molecular mechanisms research (15 papers). The work is most often cited by research in Cancer Research (985 citations), Molecular Biology (2.0k citations) and Molecular Medicine (82 citations). Lei Jiang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Junxian He, Qianfeng Li, Shaoshan Li, Lars Olof Björn, Rong Jin, Yan Wang, Jianbo Wu, Samuel S. M. Sun, Pradipsinh K. Rathod and Chunming Wang. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.